US Stock MarketDetailed Quotes
ESLAW ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)
- 0.036
- 0.0000.00%
Trading Jul 8 09:30 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.036Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.19052wk High0.00P/B0Float Cap0.02752wk Low--Dividend TTM0Shs Float0.190Historical High--Div YieldTTM0.00%Amplitude0.027Historical Low--Avg Price1Lot Size
About ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) Company
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies with the capacity to address treatment and safety challenges for patients with blood cancers and solid tumors. The company is headquartered in Emeryville, CA.
Company Profile
SymbolESLAW
Company NameESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)
Listing DateSep 14, 2021
CEODr. Cheng Liu, PhD
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5858 Horton Street,Suite 370
CityEmeryville
ProvinceCalifornia
CountryUnited States of America
Zip Code94608
Phone1-510-318-9098
Websitehttps://www.estrellabio.com
Company Executives
- Name
- Position
- Salary
- Dr. Cheng Liu, PhD
- Chief Executive Officer, President and Director
- --
- Qian Yang
- Chief Operating Officer
- --
- Jiandong Xu
- Chief Financial Officer
- --
- Pei Xu
- Independent Director
- --
- Janelle Wu
- Independent Director
- --
- Fan Wu
- Independent Director
- --
- Dr. Marsha Roberts
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg